01.06.2018 kl 15:56 6172
Oslo, 1 June 2018: Reference is made to the stock exchange announcement dated
28 May 2018 regarding the result of the subsequent repair issue of up to
4,464,286 new shares (the "Offer Shares") in Vistin Pharma ASA ("Vistin Pharma"
or the "Company") at a subscription price of NOK 11.20 per share (the
"Subsequent Repair Issue").
The share capital increase pertaining to the Subsequent Repair Issue has now
been registered in the Norwegian Register of Business Enterprises. The new share
capital of the Company is NOK 44,344,592 divided into 44,344,592 Shares, with
each Share having a nominal value of NOK 1.00.
The new shares issued in the Subsequent Repair Issue will be listed on Oslo
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
For further information, please contact:
+47 951 79 190
Vennligst skriv inn kommentar på hva du mener er upassende og trykk send. Dersom kommentar ikke er nødvendig, vennligst trykk send direkte.